Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 31 05 2019
accepted: 29 08 2019
entrez: 2 10 2019
pubmed: 2 10 2019
medline: 27 10 2020
Statut: epublish

Résumé

Persistent immune activation in virologically suppressed HIV-1 patients, which may be the consequence of various factors including microbial translocation, is a major cause of comorbidities. We have previously shown that different profiles of immune activation may be distinguished in virological responders. Here, we tested the hypothesis that a particular profile might be the consequence of microbial translocation. To this aim, we measured 64 soluble and cell surface markers of inflammation and CD4+ and CD8+ T-cell, B cell, monocyte, NK cell, and endothelial activation in 140 adults under efficient antiretroviral therapy, and classified patients and markers using a double hierarchical clustering analysis. We also measured the plasma levels of the microbial translocation markers bacterial DNA, lipopolysaccharide binding protein (LBP), intestinal-fatty acid binding protein, and soluble CD14. We identified five different immune activation profiles. Patients with an immune activation profile characterized by a high percentage of CD38+CD8+ T-cells and a high level of the endothelial activation marker soluble Thrombomodulin, presented with higher LBP mean (± SEM) concentrations (33.3 ± 1.7 vs. 28.7 ± 0.9 μg/mL,

Identifiants

pubmed: 31572392
doi: 10.3389/fimmu.2019.02185
pmc: PMC6753629
doi:

Substances chimiques

Biomarkers 0
DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2185

Informations de copyright

Copyright © 2019 Younas, Psomas, Reynes, Cezar, Kundura, Portales, Merle, Atoui, Fernandez, Le Moing, Barbuat, Moranne, Sotto, Sabatier, Fabbro, Vincent, Dunyach-Remy, Winter, Reynes, Lavigne and Corbeau.

Références

N Engl J Med. 2001 Aug 9;345(6):408-16
pubmed: 11496851
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
PLoS One. 2014 May 12;9(5):e97171
pubmed: 24819230
HIV Med. 2013 Jul;14(6):354-61
pubmed: 23332095
AIDS. 2015 Jan 2;29(1):43-51
pubmed: 25387317
J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1212-8
pubmed: 22960476
Cardiovasc Res. 2002 Oct;56(1):126-34
pubmed: 12237173
Clin Infect Dis. 2010 May 15;50(10):1387-96
pubmed: 20380565
J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):425-33
pubmed: 23797689
Arthritis Rheum. 2001 Dec;44(12):2870-8
pubmed: 11762948
J Infect Dis. 2004 Feb 15;189(4):572-82
pubmed: 14767808
J Psychiatr Res. 2018 Feb;97:54-57
pubmed: 29179013
BMC Infect Dis. 2014 Sep 29;14:521
pubmed: 25266928
EBioMedicine. 2016 Jan 28;5:135-46
pubmed: 27077120
Sci Transl Med. 2013 Jul 10;5(193):193ra91
pubmed: 23843452
HIV Med. 2016 Feb;17(2):89-105
pubmed: 26452565
J Infect Dis. 2009 Apr 15;199(8):1177-85
pubmed: 19265479
AIDS. 2018 Apr 24;32(7):945-954
pubmed: 29424776
Cell Host Microbe. 2013 Sep 11;14(3):329-39
pubmed: 24034618
PLoS Pathog. 2010 Apr 08;6(4):e1000852
pubmed: 20386714
EBioMedicine. 2016 Jun;8:265-276
pubmed: 27428436
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):370-4
pubmed: 25226210
Immunol Lett. 2014 Oct;161(2):184-8
pubmed: 24487059
J Infect Dis. 2014 Oct 15;210(8):1228-38
pubmed: 24755434
Virulence. 2013 Aug 15;4(6):507-16
pubmed: 23669075
Blood. 2013 Sep 26;122(13):2282-3
pubmed: 24072848
Curr HIV/AIDS Rep. 2012 Jun;9(2):139-47
pubmed: 22528766
J Infect Dis. 2013 Aug 15;208(4):679-89
pubmed: 23687224
Mucosal Immunol. 2014 Jul;7(4):983-94
pubmed: 24399150
Microorganisms. 2017 Sep 21;5(4):null
pubmed: 28934108
PLoS Pathog. 2014 Dec 11;10(12):e1004543
pubmed: 25503054
Curr Opin HIV AIDS. 2018 Jan;13(1):73-80
pubmed: 29045252

Auteurs

Mehwish Younas (M)

Institute of Human Genetics, CNRS-Montpellier University, UMR9002, Montpellier, France.

Christina Psomas (C)

Institute of Human Genetics, CNRS-Montpellier University, UMR9002, Montpellier, France.
Infectious Diseases Department, University Hospital, Montpellier, France.

Christelle Reynes (C)

Institute for Functional Genomics, Montpellier University, UMR5203, Montpellier, France.

Renaud Cezar (R)

Immunology Department, University Hospital, Nîmes, France.

Lucy Kundura (L)

Institute of Human Genetics, CNRS-Montpellier University, UMR9002, Montpellier, France.

Pierre Portales (P)

Immunology Department, University Hospital, Montpellier, France.

Corinne Merle (C)

Infectious Diseases Department, University Hospital, Montpellier, France.

Nadine Atoui (N)

Infectious Diseases Department, University Hospital, Montpellier, France.

Céline Fernandez (C)

Infectious Diseases Department, University Hospital, Montpellier, France.

Vincent Le Moing (V)

Infectious Diseases Department, University Hospital, Montpellier, France.
IRD UMI 233, INSERM U1175, Montpellier University, Montpellier, France.
Montpellier University, Montpellier, France.

Claudine Barbuat (C)

Infectious Diseases Department, University Hospital, Nîmes, France.

Olivier Moranne (O)

Nephrology Department, University Hospital, Nîmes, France.

Albert Sotto (A)

Montpellier University, Montpellier, France.
Infectious Diseases Department, University Hospital, Nîmes, France.

Robert Sabatier (R)

Institute for Functional Genomics, Montpellier University, UMR5203, Montpellier, France.

Pascale Fabbro (P)

Medical Informatics Department, University Hospital, Nîmes, France.

Thierry Vincent (T)

Immunology Department, University Hospital, Montpellier, France.
Montpellier University, Montpellier, France.

Catherine Dunyach-Remy (C)

U1047, INSERM, Microbiology University Hospital Nîmes, Montpellier University, Nîmes, France.

Audrey Winter (A)

Institute of Human Genetics, CNRS-Montpellier University, UMR9002, Montpellier, France.

Jacques Reynes (J)

Infectious Diseases Department, University Hospital, Montpellier, France.
IRD UMI 233, INSERM U1175, Montpellier University, Montpellier, France.
Montpellier University, Montpellier, France.

Jean-Philippe Lavigne (JP)

U1047, INSERM, Microbiology University Hospital Nîmes, Montpellier University, Nîmes, France.

Pierre Corbeau (P)

Institute of Human Genetics, CNRS-Montpellier University, UMR9002, Montpellier, France.
Immunology Department, University Hospital, Nîmes, France.
Montpellier University, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH